Join us on May 21, 2020 at 1PM ET for the next in our “Conversations with the LRG” series. In this presentation, Executive Director, Norman Scherzer will be joined by staff member and Data Analyst, Jerry Call and by Professor David Josephy to discuss relevant scientific topics including the impact of COVID-19 on GIST patients, and thoughts on promising research for GIST. There will be a 15-minute Q & A at the end of the presentation.
You may submit questions in advance to Mary Garland, Communications Director: mgarland@liferaftgroup.org
You will also be able to submit questions during the presentation that will be answered at the end.
About the Panelists:
As founder and Executive Director of the LRG, Norman leverages his extensive experience in the communicable disease sector which included 25 years at the Center for Disease Control and from his position as Assistant Commissioner of Health for New York City, to help cancer patients both survive and thrive.
See Norman Scherzer’s presentation Personal Cancer Survival Plan and the accompaniment Personal Cancer Survival Plan (PDF)
LRG Staff member, Jerry Call, is an expert in the science and treatment of GIST. Jerry has been part of the Life Raft Group since its beginnings, and is currently serving as a Data Analyst, helping to identify vital information to help patients survive and thrive.
Read Jerry Call’s latest study, featured in LRG Science, Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry
Dr. David Josephy is a Professor of Biochemistry at the University of Guelph in Canada and serves as President of Life Raft Group Canada. He has given presentations globally on understanding the basics of GIST in his GIST 101 lecture.
See Dr. Josephy’s presentation The Biology of GIST – What Every Patient Needs to Know.
